Gemfibrozil - Lipid modification
You are here : Home > Formulary Search > Gemfibrozil - Lipid modification
Status 1
- Capsules
- Tablets
Documentation
PAD Profile
Other Indications
Below are listed other indications that Gemfibrozil is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Lipid modification.
Committee Recommendations (1)
The PCN recommends the use of fibrates for lipid modification as follows:
Familial hypercholesterolaemia - as per NICE CG71 (updated July 2016) in patients with familial hypercholesterolaemia (FH) with intolerance or contraindications to statins or ezetimibe. Patients should be offered a referral to a specialist with expertise in FH for consideration for treatment with either a bile acid sequestrant (resin), nicotinic acid or a fibrate to reduce their LDL-C concentration. For these patients, fibrates should be considered BLUE (no information sheet) on the traffic light system. Specialists to initiate treatment or make a recommendation for the primary care prescriber to initiate treatment.
Hypertriglyceridaemia - as a treatment option for patients with hypertriglyceridaemia (>10mmol/L).
BLUE traffic light status - Specialists to initiate treatment or make a recommendation for the primary care prescriber to initiate treatment.
Policy statements and further information below.